Beatrix Stelte-Ludwig

Person

Wuelfrath, DE

People

Patents Grantslast 30 patents

Information Patent Grant
Antibody drug conjugates with enzymatically cleavable groups
- Patent number 12,144,865
- Issue date Nov 19, 2024
- Bayer Pharma Aktiengesellschaft
- Hans-Georg Lerchen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of treatment using CCR8 antibodies
- Patent number 12,065,497
- Issue date Aug 20, 2024
- Bayer Aktiengesellschaft
- Sandra Berndt
- G01 - MEASURING TESTING
Information Patent Grant
Prodrugs of cytotoxic active agents having enzymatically cleavable...
- Patent number 12,059,472
- Issue date Aug 13, 2024
- Bayer Aktiengesellschaft
- Hans-Georg Lerchen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Site specific homogeneous with KSP inhibitors
- Patent number 11,806,404
- Issue date Nov 7, 2023
- Bayer Pharma Aktiengesellschaft
- Hans-Georg Lerchen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Prodrugs of cytotoxic active agents having enzymatically cleavable...
- Patent number 11,685,714
- Issue date Jun 27, 2023
- Bayer Pharma Aktiengesellschaft
- Hans-Georg Lerchen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody drug conjugates (ADCs) having enzymatically cleavable groups
- Patent number 11,660,351
- Issue date May 30, 2023
- Bayer Aktiengesellschaft
- Hans-Georg Lerchen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Specific antibody-drug-conjugates (ADCs) with KSP inhibitors and an...
- Patent number 11,643,469
- Issue date May 9, 2023
- Bayer Pharma Aktiengesellschaft
- Hans-Georg Lerchen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody drug conjugates (ADCS) having enzymatically cleavable groups
- Patent number 11,478,554
- Issue date Oct 25, 2022
- Bayer Pharma Aktiengesellschaft
- Hans-Georg Lerchen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Specific antibody drug conjugates (ADCs) having KSP inhibitors
- Patent number 11,433,140
- Issue date Sep 6, 2022
- Bayer Pharma Aktiengesellschaft
- Hans-Georg Lerchen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody drug conjugates (ADCS) and antibody prodrug conjugates (AP...
- Patent number 11,123,439
- Issue date Sep 21, 2021
- Bayer Pharma Aktiengesellschaft
- Hans-Georg Lerchen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody drug conjugates of kinesin spindel protein (KSP) inhibitor...
- Patent number 11,071,788
- Issue date Jul 27, 2021
- Bayer Pharma Aktiengesellschaft
- Hans-Georg Lerchen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Specific antibody-drug-conjugates (ADCs) with KSP inhibitors and an...
- Patent number 11,001,636
- Issue date May 11, 2021
- Bayer Pharma Aktiengesellschaft
- Hans-Georg Lerchen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Site specific homogeneous with KSP inhibitors
- Patent number 10,973,923
- Issue date Apr 13, 2021
- Bayer Pharma Aktiengesellschaft
- Hans-Georg Lerchen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody drug conjugates of kinesin spindel protein (KSP) inhibitor...
- Patent number 10,744,205
- Issue date Aug 18, 2020
- Bayer Pharma Aktiengesellschaft
- Hans-Georg Lerchen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibody-drug conjugates (ADCs) of KSP inhibitors with aglycosylate...
- Patent number 10,485,880
- Issue date Nov 26, 2019
- Bayer Pharma Aktiengesellschaft
- Hans-Georg Lerchen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody drug conjugates (ADCs) with kinesin spindel protein (KSP)
- Patent number 10,022,453
- Issue date Jul 17, 2018
- Bayer Pharma Aktiengesellschaft
- Hans-Georg Lerchen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
N-carboxyalkylauristatins and use thereof
- Patent number 9,029,406
- Issue date May 12, 2015
- Seattle Genetics, Inc.
- Hans-Georg Lerchen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Binder-drug conjugates (ADCs) and use thereof
- Patent number 8,992,932
- Issue date Mar 31, 2015
- Seattle Genetics, Inc.
- Hans-Georg Lerchen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
N-carboxyalkyl-auristatin and the use thereof
- Patent number 8,987,209
- Issue date Mar 24, 2015
- Seattle Genetics, Inc.
- Hans-Georg Lerchen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Auristatin derivatives and use thereof
- Patent number 8,722,629
- Issue date May 13, 2014
- Seattle Genetics, Inc.
- Hans-Georg Lerchen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Biphenyl and biphenyl-analogous compounds as integrin antagonists
- Patent number 7,094,911
- Issue date Aug 22, 2006
- Bayer Aktiengesellschaft
- Markus Albers
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Biphenyl and biphenyl-analogous compounds as integrin antagonists
- Patent number 6,677,360
- Issue date Jan 13, 2004
- Bayer Aktiengesellschaft
- Markus Albers
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
β-phenylalanine derivatives as integrin antagonists
- Patent number 6,589,972
- Issue date Jul 8, 2003
- Bayer Aktiengesellschaft
- Andreas Schoop
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
1,4-benzodiazepinone derivatives and their use as integrin antagonists
- Patent number 6,495,545
- Issue date Dec 17, 2002
- Bayer Aktiengesellschaft
- Klaus Urbahns
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Biphenyl and biphenyl-analogous compounds as integrin antagonists
- Patent number 6,420,396
- Issue date Jul 16, 2002
- Beiersdorf AG
- Markus Albers
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Multiheterocyclic pharmAceuticals
- Patent number 6,339,083
- Issue date Jan 15, 2002
- Bayer Aktiengesellschaft
- Klaus Urbahns
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
β-phenylalanine derivatives as integrin antagonists
- Patent number 6,291,503
- Issue date Sep 18, 2001
- Bayer Aktiengesellschaft
- Andreas Schoop
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS FOR THE TREATME...
- Publication number 20240423973
- Publication date Dec 26, 2024
- VINCERX PHARMA GMBH
- Hans-Georg LERCHEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS FOR THE TREATME...
- Publication number 20240408222
- Publication date Dec 12, 2024
- VINCERX PHARMA GMBH
- Hans-Georg LERCHEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CCR8 ANTIBODIES FOR THERAPEUTIC APPLICATIONS
- Publication number 20240400700
- Publication date Dec 5, 2024
- Bayer Aktiengesellschaft
- Sandra Berndt
- G01 - MEASURING TESTING
Information Patent Application
CCR8 ANTIBODIES FOR THERAPEUTIC APPLICATIONS
- Publication number 20240376218
- Publication date Nov 14, 2024
- Bayer Aktiengesellschaft
- Sandra Berndt
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SELECTIVE CDK9 INHIBITOR FOR THE TREATMENT OF A RAS MUTANT CANCER
- Publication number 20240325366
- Publication date Oct 3, 2024
- VINCERX PHARMA, INC.
- Sooin HWANG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CYTOSTATIC CONJUGATES WITH INTEGRIN LIGANDS
- Publication number 20240325553
- Publication date Oct 3, 2024
- BAYER PHARMA AKTIENGESELLSCHAFT
- Hans-Georg LERCHEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PRODRUGS OF CYTOTOXIC ACTIVE AGENTS HAVING ENZYMATICALLY CLEAVABLE...
- Publication number 20240043379
- Publication date Feb 8, 2024
- BAYER PHARMA AKTIENGESELLSCHAFT
- Hans-Georg LERCHEN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SPECIFIC ANTIBODY-DRUG-CONJUGATES (ADCS) WITH KSP INHIBITORS AND AN...
- Publication number 20230399411
- Publication date Dec 14, 2023
- BAYER PHARMA AKTIENGESELLSCHAFT
- Hans-Georg LERCHEN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODY DRUG CONJUGATES (ADCS) HAVING ENZYMATICALLY CLEAVABLE GROUPS
- Publication number 20230338559
- Publication date Oct 26, 2023
- BAYER PHARMA AKTIENGESELLSCHAFT
- Hans-Georg LERCHEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SULFATED PEPTIDES FOR CHEMOKINE RECEPTOR ANTIBODY GENERATION
- Publication number 20230250178
- Publication date Aug 10, 2023
- Bayer Aktiengesellschaft
- Sandra BERNDT
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY DRUG CONJUGATES (ADCS) AND ANTIBODY PRODRUG CONJUGATES (AP...
- Publication number 20230039341
- Publication date Feb 9, 2023
- BAYER PHARMA AKTIENGESELLSCHAFT
- Hans-Georg LERCHEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SPECIFIC ANTIBODY DRUG CONJUGATES (ADCS) HAVING KSP INHIBITORS
- Publication number 20220362392
- Publication date Nov 17, 2022
- BAYER PHARMA AKTIENGESELLSCHAFT
- Hans-Georg LERCHEN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SPECIFIC ANTIBODY-DRUG-CONJUGATES (ADCS) WITH KSP INHIBITORS AND AN...
- Publication number 20220267457
- Publication date Aug 25, 2022
- BAYER PHARMA AKTIENGESELLSCHAFT
- Hans-Georg LERCHEN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODY DRUG CONJUGATES (ADCS) HAVING ENZYMATICALLY CLEAVABLE GROUPS
- Publication number 20220016258
- Publication date Jan 20, 2022
- BAYER PHARMA AKTIENGESELLSCHAFT
- Hans-Georg LERCHEN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CYTOSTATIC CONJUGATES WITH INTEGRIN LIGANDS
- Publication number 20210386864
- Publication date Dec 16, 2021
- BAYER PHARMA AKTIENGESELLSCHAFT
- Hans-Georg LERCHEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BINDER/ACTIVE AGENT CONJUGATES DIRECTED AGAINST CXCR5, HAVING ENZYM...
- Publication number 20210275686
- Publication date Sep 9, 2021
- Bayer Aktiengesellschaft
- Sarah Anna Liesa JOHANNES
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SITE SPECIFIC HOMOGENEOUS WITH KSP INHIBITORS
- Publication number 20210252161
- Publication date Aug 19, 2021
- BAYER PHARMA AKTIENGESELLSCHAFT
- Hans-Georg LERCHEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SPECIFIC ANTIBODY-DRUG-CONJUGATES (ADCS) WITH KSP INHIBITORS AND AN...
- Publication number 20210230284
- Publication date Jul 29, 2021
- BAYER PHARMA AKTIENGESELLSCHAFT
- Hans-Georg LERCHEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY DRUG CONJUGATES (ADCS) WITH NAMPT INHIBITORS
- Publication number 20200360531
- Publication date Nov 19, 2020
- Bayer Aktiengesellschaft
- Niels BÖHNKE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODY DRUG CONJUGATES OF KINESIN SPINDEL PROTEIN (KSP) INHIBITOR...
- Publication number 20200138970
- Publication date May 7, 2020
- BAYER PHARMA AKTIENGESELLSCHAFT
- Hans-Georg LERCHEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SPECIFIC ANTIBODY DRUG CONJUGATES (ADCS) HAVING KSP INHIBITORS
- Publication number 20190365916
- Publication date Dec 5, 2019
- BAYER PHARMA AKTIENGESELLSCHAFT
- Hans-Georg LERCHEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PRODRUGS OF CYTOTOXIC ACTIVE AGENTS HAVING ENZYMATICALLY CLEAVABLE...
- Publication number 20190351066
- Publication date Nov 21, 2019
- Bayer Aktiengesellschaft
- Hans-Georg LERCHEN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODY DRUG CONJUGATES (ADCS) HAVING ENZYMATICALLY CLEAVABLE GROUPS
- Publication number 20190328897
- Publication date Oct 31, 2019
- BAYER PHARMA AKTIENGESELLSCHAFT
- Hans-Georg LERCHEN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SPECIFIC ANTIBODY-DRUG-CONJUGATES (ADCS) WITH KSP INHIBITORS AND AN...
- Publication number 20190330357
- Publication date Oct 31, 2019
- BAYER PHARMA AKTIENGESELLSCHAFT
- Hans-Georg LERCHEN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SITE SPECIFIC HOMOGENEOUS WITH KSP INHIBITORS
- Publication number 20190262463
- Publication date Aug 29, 2019
- BAYER PHARMA AKTIENGESELLSCHAFT
- Hans-Georg LERCHEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PRODRUGS OF CYTOTOXIC ACTIVE AGENTS HAVING ENZYMATICALLY CLEAVABLE...
- Publication number 20190077752
- Publication date Mar 14, 2019
- BAYER PHARMA AKTIENGESELLSCHAFT
- Hans-Georg LERCHEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY DRUG CONJUGATES OF KINESIN SPINDEL PROTEIN (KSP) INHIBITOR...
- Publication number 20180318438
- Publication date Nov 8, 2018
- BAYER PHARMA AKTIENGESELLSCHAFT
- Hans-Georg LERCHEN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODY DRUG CONJUGATES OF KINESIN SPINDEL PROTEIN (KSP) INHIBITOR...
- Publication number 20180318437
- Publication date Nov 8, 2018
- BAYER PHARMA AKTIENGESELLSCHAFT
- Hans-Georg LERCHEN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODY DRUG CONJUGATES OF KINESIN SPINDEL PROTEIN (KSP) INHIBITOR...
- Publication number 20180185510
- Publication date Jul 5, 2018
- BAYER PHARMA AKTIENGESELLSCHAFT
- Hans-Georg LERCHEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY DRUG CONJUGATES (ADCS) AND ANTIBODY PRODRUG CONJUGATES (AP...
- Publication number 20180169256
- Publication date Jun 21, 2018
- BAYER PHARMA AKTIENGESELLSCHAFT
- Hans-Georg LERCHEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Beatrix Stelte-Ludwig

Person

Patents Grantslast 30 patents

Antibody drug conjugates with enzymatically cleavable groups

Methods of treatment using CCR8 antibodies

Prodrugs of cytotoxic active agents having enzymatically cleavable...

Site specific homogeneous with KSP inhibitors

Prodrugs of cytotoxic active agents having enzymatically cleavable...

Antibody drug conjugates (ADCs) having enzymatically cleavable groups

Specific antibody-drug-conjugates (ADCs) with KSP inhibitors and an...

Antibody drug conjugates (ADCS) having enzymatically cleavable groups

Specific antibody drug conjugates (ADCs) having KSP inhibitors

Antibody drug conjugates (ADCS) and antibody prodrug conjugates (AP...

Antibody drug conjugates of kinesin spindel protein (KSP) inhibitor...

Specific antibody-drug-conjugates (ADCs) with KSP inhibitors and an...

Site specific homogeneous with KSP inhibitors

Antibody drug conjugates of kinesin spindel protein (KSP) inhibitor...

Antibody-drug conjugates (ADCs) of KSP inhibitors with aglycosylate...

Antibody drug conjugates (ADCs) with kinesin spindel protein (KSP)

N-carboxyalkylauristatins and use thereof

Binder-drug conjugates (ADCs) and use thereof

N-carboxyalkyl-auristatin and the use thereof

Auristatin derivatives and use thereof

Biphenyl and biphenyl-analogous compounds as integrin antagonists

Biphenyl and biphenyl-analogous compounds as integrin antagonists

&#x03B2;-phenylalanine derivatives as integrin antagonists

1,4-benzodiazepinone derivatives and their use as integrin antagonists

Biphenyl and biphenyl-analogous compounds as integrin antagonists

Multiheterocyclic pharmAceuticals

&#x03B2;-phenylalanine derivatives as integrin antagonists

Patents Applicationslast 30 patents

COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS FOR THE TREATME...

COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS FOR THE TREATME...

CCR8 ANTIBODIES FOR THERAPEUTIC APPLICATIONS

CCR8 ANTIBODIES FOR THERAPEUTIC APPLICATIONS

SELECTIVE CDK9 INHIBITOR FOR THE TREATMENT OF A RAS MUTANT CANCER

CYTOSTATIC CONJUGATES WITH INTEGRIN LIGANDS

PRODRUGS OF CYTOTOXIC ACTIVE AGENTS HAVING ENZYMATICALLY CLEAVABLE...

SPECIFIC ANTIBODY-DRUG-CONJUGATES (ADCS) WITH KSP INHIBITORS AND AN...

ANTIBODY DRUG CONJUGATES (ADCS) HAVING ENZYMATICALLY CLEAVABLE GROUPS

SULFATED PEPTIDES FOR CHEMOKINE RECEPTOR ANTIBODY GENERATION

ANTIBODY DRUG CONJUGATES (ADCS) AND ANTIBODY PRODRUG CONJUGATES (AP...

SPECIFIC ANTIBODY DRUG CONJUGATES (ADCS) HAVING KSP INHIBITORS

SPECIFIC ANTIBODY-DRUG-CONJUGATES (ADCS) WITH KSP INHIBITORS AND AN...

ANTIBODY DRUG CONJUGATES (ADCS) HAVING ENZYMATICALLY CLEAVABLE GROUPS

CYTOSTATIC CONJUGATES WITH INTEGRIN LIGANDS

BINDER/ACTIVE AGENT CONJUGATES DIRECTED AGAINST CXCR5, HAVING ENZYM...

SITE SPECIFIC HOMOGENEOUS WITH KSP INHIBITORS

SPECIFIC ANTIBODY-DRUG-CONJUGATES (ADCS) WITH KSP INHIBITORS AND AN...

ANTIBODY DRUG CONJUGATES (ADCS) WITH NAMPT INHIBITORS

ANTIBODY DRUG CONJUGATES OF KINESIN SPINDEL PROTEIN (KSP) INHIBITOR...

SPECIFIC ANTIBODY DRUG CONJUGATES (ADCS) HAVING KSP INHIBITORS

PRODRUGS OF CYTOTOXIC ACTIVE AGENTS HAVING ENZYMATICALLY CLEAVABLE...

ANTIBODY DRUG CONJUGATES (ADCS) HAVING ENZYMATICALLY CLEAVABLE GROUPS

SPECIFIC ANTIBODY-DRUG-CONJUGATES (ADCS) WITH KSP INHIBITORS AND AN...

SITE SPECIFIC HOMOGENEOUS WITH KSP INHIBITORS

PRODRUGS OF CYTOTOXIC ACTIVE AGENTS HAVING ENZYMATICALLY CLEAVABLE...

ANTIBODY DRUG CONJUGATES OF KINESIN SPINDEL PROTEIN (KSP) INHIBITOR...

ANTIBODY DRUG CONJUGATES OF KINESIN SPINDEL PROTEIN (KSP) INHIBITOR...

ANTIBODY DRUG CONJUGATES OF KINESIN SPINDEL PROTEIN (KSP) INHIBITOR...

ANTIBODY DRUG CONJUGATES (ADCS) AND ANTIBODY PRODRUG CONJUGATES (AP...

β-phenylalanine derivatives as integrin antagonists

β-phenylalanine derivatives as integrin antagonists